129 related articles for article (PubMed ID: 18374100)
1. Alpha-1 antitrypsin treatment of spontaneously diabetic nonobese diabetic mice receiving islet allografts.
Pileggi A; Molano RD; Song S; Zahr E; SanJose S; Villate S; Wasserfall C; Ricordi C; Atkinson MA; Inverardi L
Transplant Proc; 2008 Mar; 40(2):457-8. PubMed ID: 18374100
[TBL] [Abstract][Full Text] [Related]
2. Prolonged islet allograft survival by alpha-1 antitrypsin: the role of humoral immunity.
Molano RD; Pileggi A; Song S; Zahr E; San Jose S; Molina J; Fort A; Wasserfall C; Ricordi C; Atkinson MA; Inverardi L
Transplant Proc; 2008 Mar; 40(2):455-6. PubMed ID: 18374099
[TBL] [Abstract][Full Text] [Related]
3. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
[TBL] [Abstract][Full Text] [Related]
4. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
[TBL] [Abstract][Full Text] [Related]
5. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
[TBL] [Abstract][Full Text] [Related]
6. Permanent acceptance of mitomycin C-treated islet allograft.
Matsuyama S; Gunji T; Ise K; Sato Y; Saito T; Gotoh M
Transplantation; 2003 Jul; 76(1):65-71. PubMed ID: 12865788
[TBL] [Abstract][Full Text] [Related]
7. "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes.
Kupfer T; Beilke JN; Pham K; Buhrman J; Gill RG
Transplant Proc; 2008 Mar; 40(2):462-3. PubMed ID: 18374102
[TBL] [Abstract][Full Text] [Related]
8. Prolongation of islet allograft survival in mice by combined treatment with pravastatin and low-dose cyclosporine.
Arita S; Kasraie A; Une S; Ohtsuka S; Smith CV; Mullen Y
Cell Transplant; 2001; 10(7):639-44. PubMed ID: 11714199
[TBL] [Abstract][Full Text] [Related]
9. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
[TBL] [Abstract][Full Text] [Related]
10. The effect of transgenic expression of TGF-beta1 on transplanted islet graft survival.
Yamasaki S; Kurita N; Hata J; Moritani M; Itakura M; Shimada M
Hepatogastroenterology; 2007 Sep; 54(78):1617-21. PubMed ID: 18019678
[TBL] [Abstract][Full Text] [Related]
11. Alpha-1-antitrypsin for the improvement of autoimmunity and allograft rejection in beta cell transplantation.
Ye J; Liao YT; Jian YQ; Zhang XD; Wei P; Qi H; Deng CY; Li FR
Immunol Lett; 2013 Feb; 150(1-2):61-8. PubMed ID: 23333354
[TBL] [Abstract][Full Text] [Related]
12. Importance of hyperglycemia on the primary function of allogeneic islet transplants.
Makhlouf L; Duvivier-Kali VF; Bonner-Weir S; Dieperink H; Weir GC; Sayegh MH
Transplantation; 2003 Aug; 76(4):657-64. PubMed ID: 12973104
[TBL] [Abstract][Full Text] [Related]
13. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression.
Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y
Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299
[TBL] [Abstract][Full Text] [Related]
14. Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation.
Emamaullee JA; Stanton L; Schur C; Shapiro AM
Diabetes; 2007 May; 56(5):1289-98. PubMed ID: 17303806
[TBL] [Abstract][Full Text] [Related]
15. Prolonged islet allograft survival in diabetic mice upon macrophage depletion by clodronate-loaded erythrocytes.
Rossi L; Migliavacca B; Pierigé F; Serafini S; Sanvito F; Olivieri S; Nano R; Antonioli B; Magnani M; Bertuzzi F
Transplantation; 2008 Feb; 85(4):648-50. PubMed ID: 18347547
[TBL] [Abstract][Full Text] [Related]
16. Melatonin prolongs islet graft survival in diabetic NOD mice.
Lin GJ; Huang SH; Chen YW; Hueng DY; Chien MW; Chia WT; Chang DM; Sytwu HK
J Pineal Res; 2009 Oct; 47(3):284-92. PubMed ID: 19708865
[TBL] [Abstract][Full Text] [Related]
17. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
[TBL] [Abstract][Full Text] [Related]
18. α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection.
Shahaf G; Moser H; Ozeri E; Mizrahi M; Abecassis A; Lewis EC
Mol Med; 2011; 17(9-10):1000-11. PubMed ID: 21670848
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with epidermal growth factor and gastrin delays autoimmune diabetes recurrence in nonobese diabetic mice transplanted with syngeneic islets.
Suarez-Pinzon WL; Rabinovitch A
Transplant Proc; 2008 Mar; 40(2):529-32. PubMed ID: 18374121
[TBL] [Abstract][Full Text] [Related]
20. Prolonged allogeneic islet graft survival by protoporphyrins.
Pileggi A; Molano RD; Berney T; Ichii H; San Jose S; Zahr E; Poggioli R; Linetsky E; Ricordi C; Inverardi L
Cell Transplant; 2005; 14(2-3):85-96. PubMed ID: 15881418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
